These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27467507)

  • 1. Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
    Papadodima O; Moulos P; Koryllou A; Piroti G; Kolisis F; Chatziioannou A; Pletsa V
    PLoS One; 2016; 11(7):e0160248. PubMed ID: 27467507
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
    Kakumu T; Sato M; Goto D; Kato T; Yogo N; Hase T; Morise M; Fukui T; Yokoi K; Sekido Y; Girard L; Minna JD; Byers LA; Heymach JV; Coombes KR; Kondo M; Hasegawa Y
    Cancer Sci; 2017 Apr; 108(4):732-743. PubMed ID: 28165654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death induced by N-methyl-N-nitrosourea, a model S(N)1 methylating agent, in two lung cancer cell lines of human origin.
    Koryllou A; Patrinou-Georgoula M; Troungos C; Pletsa V
    Apoptosis; 2009 Sep; 14(9):1121-33. PubMed ID: 19634013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Analysis Reveals HgCl
    Kim MJ; Park J; Kim J; Kim JY; An MJ; Shin GS; Lee HM; Kim CH; Kim JW
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
    Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
    FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of human non-small-cell lung cancer cells to the influence of Wogonin with SGK1 dynamics.
    Shi G; Wang Q; Zhou X; Li J; Liu H; Gu J; Wang H; Wu Y; Ding L; Ni S; Tang Z
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):302-310. PubMed ID: 28338770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
    Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
    Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
    Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
    Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
    Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H
    Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
    Kobayashi S; Shimamura T; Monti S; Steidl U; Hetherington CJ; Lowell AM; Golub T; Meyerson M; Tenen DG; Shapiro GI; Halmos B
    Cancer Res; 2006 Dec; 66(23):11389-98. PubMed ID: 17145885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non-small cell lung cancer cell line A549.
    Qian X; Li J; Ding J; Wang Z; Zhang W; Hu G
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):487-94. PubMed ID: 19673930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
    Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
    Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway.
    Tsai JR; Liu PL; Chen YH; Chou SH; Cheng YJ; Hwang JJ; Chong IW
    PLoS One; 2015; 10(12):e0144462. PubMed ID: 26656720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.
    Ceppi P; Rapa I; Lo Iacono M; Righi L; Giorcelli J; Pautasso M; Billè A; Ardissone F; Papotti M; Scagliotti GV
    Int J Cancer; 2012 Apr; 130(8):1777-86. PubMed ID: 21618517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.